New Parkinson’s drug has roots at UVA Health CBS 19 NewsDecades of UVA Research Yields New Parkinson’s Drug UVA HealthFDA approves new kind of Parkinson’s pill from AbbVie Longevity.TechnologyParkinson’s Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight Yahoo FinancePhysician Views Results: AbbVie’s Juvmo may emerge first and foremost as levodopa switch agent in PD FirstWord Pharma
